Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma Meeting Abstract


Authors: Kumar, A.; Yahalom, J.; Schoder, H.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; Hamilton, A.; Hamlin, P.; Horwitz, S. M.; Jacob, A. G.; Matasar, M. J.; Mccall, S.; Moskowitz, A. J.; Noy, A.; Palomba, L.; Portlock, C. S.; Straus, D. J.; Verwys, S.; Zelenetz, A. D.; Zhang, Z. G.; Younes, A.; Moskowitz, C. H.
Abstract Title: Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma
Meeting Title: 56th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 124
Issue: 21
Meeting Dates: 2014 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2014-12-06
Language: English
ACCESSION: WOS:000349243501070
PROVIDER: wos
DOI: 10.1182/blood.V124.21.3085.3085
Notes: Meeting Abstract: 3085 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Zhigang Zhang
    310 Zhang
  2. Joachim Yahalom
    488 Yahalom
  3. Carol Portlock
    201 Portlock
  4. Craig Moskowitz
    397 Moskowitz
  5. Ariela Noy
    269 Noy
  6. Maria Lia Palomba
    219 Palomba
  7. Steven M Horwitz
    465 Horwitz
  8. Heiko Schoder
    362 Schoder
  9. Andrew D Zelenetz
    639 Zelenetz
  10. Alison Moskowitz
    212 Moskowitz
  11. Paul Hamlin
    212 Hamlin
  12. Matthew J Matasar
    180 Matasar
  13. Philip C Caron
    50 Caron
  14. David J Straus
    286 Straus
  15. Susan J McCall
    15 McCall
  16. Anita Kumar
    87 Kumar
  17. Alexandra G Jacob
    7 Jacob
  18. Anas Younes
    286 Younes
  19. Stephanie Lisl Verwys
    4 Verwys
Related MSK Work